TrialOrphanet journal of rare diseases2024

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.

Amel Karaa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.